Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

816 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oral anticoagulation and stroke in atrial fibrillation.
Folkeringa RJ, Dinh TN, Crijns HJ. Folkeringa RJ, et al. Among authors: crijns hj. N Engl J Med. 2003 Dec 11;349(24):2360-1; author reply 2360-1. doi: 10.1056/NEJM200312113492417. N Engl J Med. 2003. PMID: 14668465 No abstract available.
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ; Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. Van Gelder IC, et al. Among authors: crijns hj. N Engl J Med. 2002 Dec 5;347(23):1834-40. doi: 10.1056/NEJMoa021375. N Engl J Med. 2002. PMID: 12466507 Free article. Clinical Trial.
Aldosterone levels after angiotensin receptor blocker treatment.
Folkeringa RJ, Pinto YM, Crijns HJ. Folkeringa RJ, et al. Among authors: crijns hj. Circulation. 2004 Apr 13;109(14):e182; author reply e182. doi: 10.1161/01.CIR.0000124885.70372.41. Circulation. 2004. PMID: 15078811 No abstract available.
Non-antiarrhythmic drugs to prevent atrial fibrillation.
Folkeringa RJ, Tieleman RG, Crijns HJ. Folkeringa RJ, et al. Among authors: crijns hj. Heart Rhythm. 2004 Oct;1(4):516-8. doi: 10.1016/j.hrthm.2004.02.019. Heart Rhythm. 2004. PMID: 15851208 Review. No abstract available.
Aspirin versus vitamin K antagonist treatment guided by transoesophageal echocardiography in patients with atrial fibrillation: a pilot study.
Dinh T, Baur LH, Pisters R, Kamp O, Verheugt FW, Smeets JL, Cheriex EC, Lindeboom JE, Heesen WF, Tieleman RG, Prins MH, Crijns HJ; TIARA investigators. Dinh T, et al. Among authors: crijns hj. Heart. 2014 Apr;100(7):563-8. doi: 10.1136/heartjnl-2013-305017. Epub 2014 Jan 31. Heart. 2014. PMID: 24488608 Clinical Trial.
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
Calkins H, Willems S, Gerstenfeld EP, Verma A, Schilling R, Hohnloser SH, Okumura K, Serota H, Nordaby M, Guiver K, Biss B, Brouwer MA, Grimaldi M; RE-CIRCUIT Investigators. Calkins H, et al. N Engl J Med. 2017 Apr 27;376(17):1627-1636. doi: 10.1056/NEJMoa1701005. Epub 2017 Mar 19. N Engl J Med. 2017. PMID: 28317415 Free article. Clinical Trial.
Nurse-led vs. usual-care for atrial fibrillation.
Wijtvliet EPJP, Tieleman RG, van Gelder IC, Pluymaekers NAHA, Rienstra M, Folkeringa RJ, Bronzwaer P, Elvan A, Elders J, Tukkie R, Luermans JGLM, Van Asselt ADIT, Van Kuijk SMJ, Tijssen JG, Crijns HJGM; RACE 4 Investigators. Wijtvliet EPJP, et al. Eur Heart J. 2020 Feb 1;41(5):634-641. doi: 10.1093/eurheartj/ehz666. Eur Heart J. 2020. PMID: 31544925 Clinical Trial.
816 results